SALEKI-GERHARDT AZITA
Insider CIK 1563545 · ENTG Director · ABBV SVP, Operations
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTG ENTEGRIS INC | A Award | 2026-05-06 | 2026-05-08 | 1,412 | — | $0 | 26,383 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2026-02-27 | 2026-03-03 | 16,309 | $232.08 | $3.78M | 197,794 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2026-02-18 | 2026-02-20 | 20,312 | — | $0 | 20,312 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 6,638 | — | $0 | 214,103 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 7,074 | — | $0 | 207,465 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 17,041 | — | $0 | 194,333 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 6,058 | — | $0 | 200,391 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2025-08-12 | 2025-08-14 | 42,370 | $54.86 | $2.32M | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2025-08-12 | 2025-08-14 | 42,370 | $54.86 | $2.32M | 219,662 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-08-12 | 2025-08-14 | 42,370 | $198.42 | $8.41M | 177,292 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2025-04-23 | 2025-04-25 | 2,897 | — | $0 | 24,971 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2025-02-28 | 2025-03-04 | 17,056 | $205.02 | $3.50M | 177,292 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 7,074 | — | $0 | 232,846 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 6,060 | — | $0 | 225,772 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 7,378 | — | $0 | 219,712 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 17,986 | — | $0 | 212,334 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2024-09-24 | 2024-09-30 | 25,630 | — | $0 | 194,348 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2024-04-24 | 2024-04-25 | 1,643 | — | $0 | 22,074 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2024-02-28 | 2024-03-01 | 23,966 | $178.99 | $4.29M | 219,978 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2024-02-21 | 2024-02-23 | 52,870 | $58.88 | $3.11M | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2024-02-21 | 2024-02-23 | 52,870 | $58.88 | $3.11M | 296,814 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2024-02-21 | 2024-02-23 | 52,870 | $173.71 | $9.18M | 243,944 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2024-02-15 | 2024-02-20 | 29,313 | — | $0 | 29,313 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 6,060 | — | $0 | 243,944 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 8,558 | — | $0 | 230,504 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 32,097 | — | $0 | 221,946 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 7,380 | — | $0 | 237,884 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2023-04-26 | 2023-04-28 | 2,849 | — | $0 | 20,431 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-03-01 | 2023-03-02 | 26,990 | $51.42 | $1.39M | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-03-01 | 2023-03-02 | 26,990 | $51.42 | $1.39M | 226,839 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 26,990 | $155.00 | $4.18M | 199,849 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 9,220 | $153.05 | $1.41M | 190,629 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 780 | $153.39 | $119.6K | 189,849 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 33,359 | $154.28 | $5.15M | 199,849 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-02-17 | 2023-02-21 | 25,000 | $51.42 | $1.29M | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-02-17 | 2023-02-21 | 10,754 | $150.05 | $1.61M | 233,208 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-02-17 | 2023-02-21 | 25,000 | $51.42 | $1.29M | 258,208 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-02-17 | 2023-02-21 | 14,246 | $149.13 | $2.12M | 243,962 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 22,957 | — | $0 | 22,957 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 48,127 | — | $0 | 206,039 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 11,229 | — | $0 | 217,268 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 8,560 | — | $0 | 225,828 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 7,380 | — | $0 | 233,208 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2022-04-27 | 2022-04-29 | 1,849 | — | $0 | 17,582 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2022-02-25 | 2022-03-01 | 22,108 | $149.54 | $3.31M | 157,912 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2022-02-17 | 2022-02-22 | 35,026 | — | $0 | 35,026 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 5,568 | — | $0 | 147,464 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 11,229 | — | $0 | 158,693 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 25,612 | — | $0 | 141,896 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 13,837 | — | $0 | 180,020 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 7,490 | — | $0 | 166,183 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2021-05-24 | 2021-05-26 | 12,400 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2021-05-24 | 2021-05-26 | 74,520 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-05-24 | 2021-05-26 | 9,057 | $116.70 | $1.06M | 116,284 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2021-05-24 | 2021-05-26 | 12,400 | $29.23 | $362.5K | 128,684 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2021-05-24 | 2021-05-26 | 77,863 | $116.24 | $9.05M | 125,341 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2021-05-24 | 2021-05-26 | 74,520 | $35.88 | $2.67M | 203,204 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2021-04-29 | 2021-05-03 | 1,610 | — | $0 | 15,733 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2021-02-28 | 2021-03-02 | 15,785 | $107.74 | $1.70M | 116,284 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 42,236 | — | $0 | 42,236 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 14,552 | — | $0 | 110,993 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 5,568 | — | $0 | 120,840 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 11,229 | — | $0 | 132,069 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 4,279 | — | $0 | 115,272 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-11-10 | 2020-11-12 | 17,426 | $98.00 | $1.71M | 96,441 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2020-11-04 | 2020-11-12 | 4,800 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-11-04 | 2020-11-06 | 4,800 | $93.61 | $449.3K | 109,067 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2020-11-04 | 2020-11-12 | 4,800 | $24.21 | $116.2K | 118,667 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-11-04 | 2020-11-12 | 4,800 | $93.61 | $449.3K | 113,867 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2020-04-29 | 2020-05-01 | 2,567 | — | $0 | 14,123 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2020-02-28 | 2020-03-03 | 16,342 | $85.42 | $1.40M | 113,867 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2020-02-20 | 2020-02-24 | 73,649 | — | $0 | 73,649 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 19,880 | — | $0 | 113,192 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 7,170 | — | $0 | 120,362 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 4,279 | — | $0 | 124,641 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 5,568 | — | $0 | 130,209 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2019-05-01 | 2019-05-03 | 3,569 | — | $0 | 11,556 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2019-03-05 | 2019-03-06 | 15,797 | $79.03 | $1.25M | 93,312 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2019-02-28 | 2019-03-04 | 12,569 | $79.41 | $998.1K | 109,109 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2019-02-21 | 2019-02-22 | 34,267 | — | $0 | 34,267 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 9,835 | — | $0 | 103,147 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 7,080 | — | $0 | 110,227 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 7,170 | — | $0 | 117,397 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 4,281 | — | $0 | 121,678 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2018-05-09 | 2018-05-10 | 4,090 | — | $0 | 7,987 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2018-02-28 | 2018-03-02 | 12,683 | $118.26 | $1.50M | 94,649 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-02-28 | 2018-03-02 | 1,337 | $117.77 | $157.5K | 93,312 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 23,160 | — | $0 | 23,160 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 7,080 | — | $0 | 91,879 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 8,283 | — | $0 | 100,162 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 7,170 | — | $0 | 107,332 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2017-09-11 | 2017-09-12 | 4,800 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2017-09-11 | 2017-09-12 | 4,800 | $24.21 | $116.2K | 93,099 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-09-11 | 2017-09-12 | 1,200 | $84.99 | $102.0K | 91,899 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-09-11 | 2017-09-12 | 2,338 | $85.06 | $198.9K | 84,799 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-09-11 | 2017-09-12 | 3,600 | $85.00 | $306.0K | 88,299 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-09-11 | 2017-09-12 | 1,030 | $85.04 | $87.6K | 87,137 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-09-11 | 2017-09-12 | 132 | $85.03 | $11.2K | 88,167 | SEC↗ |
| ENTG ENTEGRIS INC | A Award | 2017-08-14 | 2017-08-15 | 3,897 | — | $0 | 3,897 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 19,096 | $62.22 | $1.19M | 88,299 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 47,870 | — | $0 | 47,870 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 15,736 | — | $0 | 100,315 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 7,080 | — | $0 | 107,395 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2017-02-02 | 2017-02-03 | 2,400 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2017-02-02 | 2017-02-03 | 2,400 | $27.29 | $65.5K | 5,431 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2017-02-02 | 2017-02-03 | 1,558 | $60.89 | $94.9K | 3,873 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2016-02-29 | 2016-03-02 | 13,608 | $56.00 | $762.0K | 86,355 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2016-02-29 | 2016-03-02 | 1,776 | $55.38 | $98.4K | 84,579 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2016-02-18 | 2016-02-22 | 42,370 | — | $0 | 42,370 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2016-02-05 | 2016-02-09 | 3,400 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2016-02-05 | 2016-02-09 | 2,112 | $56.76 | $119.9K | 3,031 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2016-02-05 | 2016-02-09 | 3,400 | $22.94 | $78.0K | 5,143 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-28 | 2015-03-03 | 4,592 | $60.50 | $277.8K | 99,963 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-27 | 2015-03-03 | 5,901 | $60.52 | $357.1K | 106,667 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2015-02-27 | 2015-03-03 | 2,112 | $60.47 | $127.7K | 104,555 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2015-02-19 | 2015-02-23 | 52,870 | — | $0 | 52,870 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2015-02-19 | 2015-02-23 | 26,740 | — | $0 | 112,568 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2015-02-09 | 2015-02-11 | 2,250 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-09 | 2015-02-11 | 1,425 | $56.90 | $81.1K | 1,743 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2015-02-09 | 2015-02-11 | 2,250 | $24.07 | $54.2K | 3,168 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 100 | $50.26 | $5.0K | 85,828 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 200 | $50.26 | $10.1K | 85,928 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 581 | $50.25 | $29.2K | 86,328 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 100 | $50.25 | $5.0K | 86,228 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 100 | $50.26 | $5.0K | 86,128 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 1,200 | $50.25 | $60.3K | 86,909 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 162 | $50.24 | $8.1K | 88,109 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2014-02-28 | 2014-03-04 | 6,336 | $51.91 | $328.9K | 88,271 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2014-02-20 | 2014-02-24 | 51,990 | — | $0 | 51,990 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2014-02-20 | 2014-02-24 | 30,140 | — | $0 | 94,607 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2014-02-10 | 2014-02-12 | 1,466 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2014-02-10 | 2014-02-12 | 1,466 | $45.06 | $66.1K | 65,856 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2014-02-10 | 2014-02-12 | 1,389 | $48.89 | $67.9K | 64,467 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-02-05 | 2014-02-07 | 300 | $47.85 | $14.4K | 64,777 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-02-05 | 2014-02-07 | 387 | $47.84 | $18.5K | 64,390 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2014-01-03 | 2014-01-07 | 1,626 | $51.98 | $84.5K | 65,077 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-12-19 | 2013-12-20 | 2,186 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-12-19 | 2013-12-20 | 304 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-12-19 | 2013-12-20 | 304 | $28.37 | $8.6K | 414 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-12-19 | 2013-12-20 | 1,682 | $54.32 | $91.4K | 918 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-12-19 | 2013-12-20 | 2,186 | $28.41 | $62.1K | 2,600 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-09-17 | 2013-09-18 | 4,600 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-09-17 | 2013-09-18 | 1,997 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-09-17 | 2013-09-18 | 3,695 | $46.00 | $170.0K | 68,492 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-09-17 | 2013-09-18 | 1,789 | $46.48 | $83.2K | 66,703 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-09-17 | 2013-09-18 | 1,997 | $37.18 | $74.2K | 72,187 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-09-17 | 2013-09-18 | 4,600 | $28.86 | $132.8K | 70,190 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 2,200 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 4,100 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-09-16 | 2013-09-18 | 4,989 | $45.50 | $227.0K | 65,590 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-09-16 | 2013-09-18 | 2,200 | $28.32 | $62.3K | 70,579 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-09-16 | 2013-09-18 | 4,100 | $27.29 | $111.9K | 68,379 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-08-19 | 2013-08-20 | 1,312 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-08-19 | 2013-08-20 | 1,312 | $37.18 | $48.8K | 65,549 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-08-19 | 2013-08-20 | 1,270 | $43.01 | $54.6K | 64,279 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-08-12 | 2013-08-13 | 6,842 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-08-12 | 2013-08-13 | 5,006 | $45.01 | $225.3K | 64,237 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-08-12 | 2013-08-13 | 6,842 | $24.07 | $164.7K | 69,243 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2013-08-09 | 2013-08-13 | 1,466 | — | $0 | 1,466 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-08-09 | 2013-08-13 | 2,158 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-08-09 | 2013-08-13 | 5,700 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-08-09 | 2013-08-13 | 1,734 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-08-09 | 2013-08-13 | 2,158 | $24.07 | $51.9K | 67,130 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-08-09 | 2013-08-13 | 5,700 | $22.94 | $130.8K | 64,972 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-08-09 | 2013-08-13 | 1,734 | $34.76 | $60.3K | 68,864 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-08-09 | 2013-08-13 | 2,618 | $45.06 | $118.0K | 62,401 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-08-09 | 2013-08-13 | 3,845 | $44.78 | $172.2K | 65,019 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-03-08 | 2013-03-12 | 496 | $37.50 | $18.6K | 59,272 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-28 | 2013-03-04 | 1,479 | $36.73 | $54.3K | 59,768 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-19 | 2013-02-19 | 421 | $37.58 | $15.8K | 61,247 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2013-02-14 | 2013-02-19 | 74,520 | — | $0 | 74,520 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2013-02-14 | 2013-02-19 | 36,480 | — | $0 | 61,668 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-02-04 | 2013-02-06 | 3,418 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-02-04 | 2013-02-06 | 3,805 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2013-02-04 | 2013-02-06 | 3,309 | — | $0 | 3,309 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-02-04 | 2013-02-06 | 3,805 | $29.40 | $111.9K | 31,615 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-04 | 2013-02-06 | 6,427 | $37.18 | $239.0K | 25,188 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-02-04 | 2013-02-06 | 3,418 | $31.95 | $109.2K | 27,810 | SEC↗ |